Internet Explorer 8 Warnung Anscheinend verwenden Sie einen älteren Internet Explorer. Leider unterstützen wir, genau wie Microsoft, diesen Browser nicht mehr. Sie werden also Fehlermeldungen und ein inkonsistentes Design erleben.
Bitte haben Sie Verständnis und entschuldigen Sie die Unannehmlichkeiten.
Logo HTGF

News

11th edition of MedTech Radar: Focusing on the healthcare of the future

9. November 2018
Digital and intelligent – that’s the healthcare of the future. Many medical technology companies already have promising products on offer. Artificial intelligence in particular has great potential. This eleventh edition of MedTech Radar, a joint media service of the Bundesverband Medizintechnologie (BVMed), Earlybird Venture Capital, the High-Tech Gründerfonds (HTGF), Germany Trade and Invest (GTAI), and BIOCOM AG, reports on ideas More …

SYNOSTE Ltd raises €5.1 million to launch its smart skeletal deformation correction technology

18. October 2018
SYNOSTE Ltd, a Finnish medical device company creates smart solutions for patient-friendly bone-lengthening and bone-deformation correction. The company, also located in Düsseldorf, Germany has raised over five million euros to start clinical investigations and to develop new clinical applications. SYNOSTE’s patented technology platform provides the basis for further disruptive changes in the treatment of congenital, trauma- and tumour-related limb discrepancies, More …

High-Tech Gründerfonds invests in medical engineering of the future

17. October 2018
Kumovis develops 3D printers specifically for medical technology. With its technology the team of Kumovis enables the manufacturing of individualized medical products, like patient-customized implants. The HTGF now participates in the seed financing round. This investment especially supports Kumovis‘ market launch of the innovative printers. The founders of Kumovis have set themselves the goal of enabling the additive production of More …

c-LEcta lays foundation for further growth and closes financing round

23. August 2018
Closing of financing round with new investors Capricorn and bm|t brings growth capital and valuable access to international network Growth financing to take c-LEcta to a new level by upscaling food ingredients manufacturing to commercial production in a multi-billion-euro market New CFO Thomas Pfaadt to manage and support growth   c-LEcta, a world-leading biotechnology company focused on enzyme engineering and More …

Pet therapeutic antibody firm adivo announces closure of seed-financing round

20. August 2018
German biotech company adivo specializing in generating species-specific therapeutic antibodies for companion animals announces that it received a seed financing from three investors. The adivo team aims to address high medical needs in dogs including cancer and chronic inflammation, with the potential of expanding activities into the development of therapeutics for other species in the future. “Now, we are very More …

The High-Tech Gründerfonds (HTGF) invests together with MIG Fonds and Business Angels about 2.5 million Euro in the medical technology start-up GWA Hygiene from Stralsund

10. August 2018
The GWA Hygiene is fighting hospital germs and thus reducing the risk of their spread. The company from Stralsund combines innovative medical technology with modern information technology. The NosoEx system developed by the startup has already successfully passed the practical test at 70 wards in 10 hospitals. Germ transmission due to improper hand disinfection GWA Hygiene offers hospitals and nursing More …

Bruker takes over HTGF startup Sierra Sensors, rounding off the pharmaceutical research portfolio

25. June 2018
Sierra Sensors’ biosensor technologies will from now on be distributed worldwide. Thanks to its innovative, patented sensor technologies, a portfolio company in the High-Tech Gründerfond (HTGF) has reached market maturity: USA’s Bruker Corporation has taken over Hamburg startup Sierra Sensors GmbH. Sierra Sensors develop and distribute biosensor-based analytical tools and materials for pharmaceutical research. In addition, the company combines innovative More …

Spin-off of Neu-Ulm-based medical device producer develops drug to treat skin cancer – Zimmer BioTech expands development team

28. May 2018
In Dr. Reinhold Gahlmann and Stuart Marcus, Neu-Ulm-based Zimmer BioTech has now hired two experts in the field of pharmaceutical development. As Head of Clinical Development, Dr. Gahlmann will be responsible for establishing and implementing the clinical development programme right through to obtaining marketing authorisation for drugs. He will be assisted in his role by Stuart Marcus, who will assume More …

Focus on Start-up Pitch Day: BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 10”

28. March 2018
Strategic co-operation between medical technology firms and start-ups could foster more innovation within the industry and be a decisive factor in the success of small and medium-sized businesses (SMEs). This is particularly true in light of the increasingly complex regulatory market environment through the new EU Medical Device Regulation (MDR) which came into effect almost a year ago. Which advantages More …

Migraines & headaches app M-sense receives seven-figure sum in follow-up financing

19. January 2018
Additional financing round to help expand treatment offering and open the brand up to new markets Migraine app M-sense allows users to follow a personalised and mobile migraine treatment plan, and can also learn from user data. The certified medical product is Newsenselab GmbH’s first application and has not only racked up around 80,000 users but also a number of More …